By Associate Professor Nicole Marie Jones

Journal articles

Biswas B; Eapen V; Morris MJ; Jones NM, 2024, 'Combined Effect of Maternal Separation and Early-Life Immune Activation on Brain and Behaviour of Rat Offspring', Biomolecules, 14, http://dx.doi.org/10.3390/biom14020197

Jones NM; Nathanson AD; Chell S; DeAngelis E; Whelan G; Willé D; Cheng K, 2022, 'The prolyl hydroxylase inhibitor GSK1120360A reduces early brain injury, but protection is not maintained in a neonatal rat model of hypoxic ischaemic encephalopathy', International Journal of Developmental Neuroscience, 82, pp. 423 - 435, http://dx.doi.org/10.1002/jdn.10199

Bulbul L; Power JM; Jones NM; Kumar NN, 2022, 'Long-term hypercapnia does not alter Galanin immunoreactivity in mouse brain respiratory and chemoreceptor regions', FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36, http://dx.doi.org/10.1096/fasebj.2022.36.S1.R2326

Finney CA; Shvetcov A; Westbrook RF; Morris MJ; Jones NM, 2021, 'Tamoxifen offers long-term neuroprotection after hippocampal silent infarct in male rats', Hormones and Behavior, 136, http://dx.doi.org/10.1016/j.yhbeh.2021.105085

Finney CA; Shvetcov A; Westbrook RF; Morris MJ; Jones NM, 2021, 'The selective estrogen receptor modulator tamoxifen protects against subtle cognitive decline and early markers of injury 24 h after hippocampal silent infarct in male Sprague-Dawley rats', Hormones and Behavior, 134, http://dx.doi.org/10.1016/j.yhbeh.2021.105016

Richardson NL; O'Malley LJ; Weissberger D; Tumber A; Schofield CJ; Griffith R; Jones NM; Hunter L, 2021, 'Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2', Bioorganic and Medicinal Chemistry, 38, http://dx.doi.org/10.1016/j.bmc.2021.116115

Finney CA; Morris MJ; Westbrook RF; Jones NM, 2021, 'Hippocampal silent infarct leads to subtle cognitive decline that is associated with inflammation and gliosis at twenty-four hours after injury in a rat model', Behavioural Brain Research, 401, http://dx.doi.org/10.1016/j.bbr.2020.113089

Finney CA; Jones NM; Morris MJ, 2021, 'A scalable, fully automated approach for regional quantification of immunohistochemical staining of astrocytes in the rat brain', Journal of Neuroscience Methods, 348, http://dx.doi.org/10.1016/j.jneumeth.2020.108994

Coleman JLJ; Ngo T; Smythe RE; Cleave AJ; Jones NM; Graham RM; Smith NJ, 2020, 'The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-020-76384-9

Finney CA; Shvetcov A; Westbrook RF; Jones NM; Morris MJ, 2020, 'The role of hippocampal estradiol in synaptic plasticity and memory: A systematic review', Frontiers in Neuroendocrinology, 56, http://dx.doi.org/10.1016/j.yfrne.2019.100818

Finney C; Morris M; Westbrook F; Jones N, 2020, 'Hippocampal silent infarct leads to subtle cognitive decline that is associated with inflammation and gliosis at twenty-four hours after injury in a rat model', , http://dx.doi.org/10.1101/2020.09.29.318204

Coleman J; Ngo T; Smythe R; Cleave A; Jones N; Graham R; Smith N, 2020, 'The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases', , http://dx.doi.org/10.1101/2020.06.27.174847

Finney C; Shvetcov A; Westbrook F; Morris M; Jones N, 2020, 'The selective estrogen receptor modulator tamoxifen protects against subtle cognitive decline and early markers of injury twenty-four hours after hippocampal silent infarct', , http://dx.doi.org/10.1101/2020.11.15.383737

Coleman JLJ; Ngo T; Schmidt J; Mrad N; Liew CK; Jones NM; Graham RM; Smith NJ, 2019, 'Retraction: Metalloprotease cleavage of the N terminus of the orphan G protein-coupled receptor GPR37L1 reduces its constitutive activity (Science Signaling (2016) 9 (ra36) DOI: 10.1126/scisignal.aad1089)', Science Signaling, 12, http://dx.doi.org/10.1126/scisignal.aba2063

Penny TR; Sutherland AE; Mihelakis JG; Paton MCB; Pham Y; Lee J; Jones NM; Jenkin G; Fahey MC; Miller SL; McDonald CA, 2019, 'Human umbilical cord therapy improves long-term behavioral outcomes following neonatal hypoxic ischemic brain injury', Frontiers in Physiology, 10, http://dx.doi.org/10.3389/fphys.2019.00283

Jones N; Fath T; Nguyen H, 2019, 'The prolyl hydroxylase inhibitor – ethyl-3,4-dihydroxy benzoate (EDHB) can enhance functional recovery and reduce injury severity in a rodent model of endothelin-1 induced focal stroke', IBRO Reports, 6, pp. S485 - S485, http://dx.doi.org/10.1016/j.ibror.2019.07.1523

Nguyen HL; Ruhoff AM; Fath T; Jones NM, 2018, 'Hypoxic postconditioning enhances functional recovery following endothelin-1 induced middle cerebral artery occlusion in conscious rats', Experimental Neurology, 306, pp. 177 - 189, http://dx.doi.org/10.1016/j.expneurol.2018.05.018

McDonald CA; Penny TR; Paton MCB; Sutherland AE; Nekkanti L; Yawno T; Castillo-Melendez M; Fahey MC; Jones NM; Jenkin G; Miller SL, 2018, 'Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic-ischemic brain injury', Journal of Neuroinflammation, 15, http://dx.doi.org/10.1186/s12974-018-1089-5

Polly P; Thai T; Yang JL; Luo A; Herbert C; Jones N; Lewis T; Vickery R; Richardson A; Schibeci S, 2018, 'The teacher-student journey: Program-wide teamwork skills development and evaluation in the medical sciences', International Journal of Assessment and Evaluation, 24, pp. 1 - 24, http://dx.doi.org/10.18848/2327-7920/cgp/v24i04/1-24

Jones NM; Fath T; Nguyen HL, 2018, 'The neuroprotective effect of desferrioxamine is mediated by hypoxia-inducible factor-1 (HIF-1) in rat organotypic hippocampal slices', Proceedings for Annual Meeting of The Japanese Pharmacological Society, WCP2018, http://dx.doi.org/10.1254/jpssuppl.wcp2018.0_po2-1-58

Chan YL; Saad S; Machaalani R; Oliver BG; Vissel B; Pollock C; Jones NM; Chen H, 2017, 'Maternal cigarette smoke exposure worsens neurological outcomes in adolescent offspring with hypoxic-ischemic injury', Frontiers in Molecular Neuroscience, 10, pp. 306, http://dx.doi.org/10.3389/fnmol.2017.00306

Teo JD; Morris MJ; Jones NM, 2017, 'Hypoxic postconditioning improves behavioural deficits at 6 weeks following hypoxic-ischemic brain injury in neonatal rats', Behavioural Brain Research, 333, pp. 27 - 34, http://dx.doi.org/10.1016/j.bbr.2017.06.036

Teo JD; Morris MJ; Jones NM, 2017, 'Maternal obesity increases inflammation and exacerbates damage following neonatal hypoxic-ischaemic brain injury in rats', Brain, Behavior, and Immunity, 63, pp. 186 - 196, http://dx.doi.org/10.1016/j.bbi.2016.10.010

Chan YL; Saad S; Al-Odat I; Oliver BG; Pollock C; Jones NM; Chen H, 2017, 'Maternal L-carnitine supplementation improves brain health in offspring from cigarette smoke exposed mothers', Frontiers in Molecular Neuroscience, 10, http://dx.doi.org/10.3389/fnmol.2017.00033

Chan YL; Saad S; Al-Odat I; Zaky AA; Oliver B; Pollock C; Li W; Jones NM; Chen H, 2016, 'Impact of maternal cigarette smoke exposure on brain and kidney health outcomes in female offspring', Clinical and Experimental Pharmacology and Physiology, 43, pp. 1168 - 1176, http://dx.doi.org/10.1111/1440-1681.12659

Yang J-L; Polly P; Fath T; Jones NM; Power J, 2016, 'ISA model and integrative career development learning in year three science courses', Int J Science Math Tech Learning, 23, pp. 33 - 46

Chan YL; Saad S; Pollock C; Oliver B; Al-Odat I; Zaky AA; Jones N; Chen H, 2016, 'Impact of maternal cigarette smoke exposure on brain inflammation and oxidative stress in male mice offspring', Scientific Reports, 6, http://dx.doi.org/10.1038/srep25881

Coleman JLJ; Ngo T; Schmidt J; Mrad N; Liew CK; Jones NM; Graham RM; Smith NJ, 2016, 'Metalloprotease cleavage of the N terminus of the orphan G protein-coupled receptor GPR37L1 reduces its constitutive activity', Science Signaling, 9, http://dx.doi.org/10.1126/scisignal.aad1089

Lizarme Y; Wangsahardja J; Marcolin GM; Morris JC; Jones NM; Hunter L, 2016, 'Synthesis and neuroprotective activity of dictyoquinazol A and analogues', Bioorganic and Medicinal Chemistry, 24, pp. 1480 - 1487, http://dx.doi.org/10.1016/j.bmc.2016.02.016

Chu HX; Jones NM, 2016, 'Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic–Ischemic Injury in the Neonatal Rat', Neurochemical Research, 41, pp. 515 - 522, http://dx.doi.org/10.1007/s11064-015-1641-y

Teo JD; Morris MJ; Jones NM, 2015, 'Hypoxic postconditioning reduces microglial activation, astrocyte and caspase activity, and inflammatory markers after hypoxia-ischemia in the neonatal rat brain', Pediatric Research, 77, pp. 757 - 764, http://dx.doi.org/10.1038/pr.2015.47

Parmar J; Jones NM, 2015, 'Hypoxic preconditioning can reduce injury-induced inflammatory processes in the neonatal rat brain', International Journal of Developmental Neuroscience, 43, pp. 35 - 42, http://dx.doi.org/10.1016/j.ijdevneu.2015.03.010

Suryana E; Jones NM, 2014, 'The effects of hypoxic preconditioning on white matter damage following hypoxic-ischaemic injury in the neonatal rat brain', International Journal of Developmental Neuroscience, 37, pp. 69 - 75, http://dx.doi.org/10.1016/j.ijdevneu.2014.06.007

Jones N; Galle A, 2013, 'The neuroprotective actions of hypoxic preconditioning and postconditioning in a neonatal rat model of hypoxic ischemic brain injury', Brain Research, http://dx.doi.org/10.1016/j.brainres.2012.12.026

Chu P; Beart P; Jones N, 2010, 'Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes', European Journal of Pharmacology, 633, pp. 24 - 32, http://dx.doi.org/10.1016/j.ejphar.2010.02.008

Jones N; Kardashyan L; Callaway J; Lee E; Beart PM, 2008, 'Long-term functional and protective actions of preconditioning with hypoxia, cobalt chloride, and desferrioxamine against hypoxic-ischemic injury in neonatal rats', Pediatric Research, 63, pp. 620 - 624, http://dx.doi.org/10.1203/PDR.0b013e31816d9117

Weston R; Jarrott B; Jones N; Callaway J, 2007, 'Inflammatory cell infiltration following endothelin-1-induced cerebral ischemia: Histochemical and myeloperoxidase correlation with temporal changes in brain injury', Journal of Cerebral Blood Flow and Metabolism, 27, pp. 100 - 114, http://dx.doi.org/10.1038/sj.jcbfm.9600324

O''shea R; Lau C; Farso M; Diwakarla S; Zagami C; Svendsen B; Feeney S; Callaway J; Jones N; Pow D; Danbolt N; Jarrott B; Beart P, 2006, 'Effects of lipopolysaccharide on glial phenotype and activity of glutamate transporters: evidence for delayed up-regulation and redistribution of GLT-1', Neurochemistry International, 48, pp. 604 - 610, http://dx.doi.org/10.1016/j.neuint.2005.12.028

Jones N; Lee E; Brown T; Jarrott B; Beart P, 2006, 'Hypoxic preconditioning produces differential expression of Hypoxia-inducible factor - 1á (HIF-1á) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain', Neuroscience Letters, 404, pp. 72 - 77, http://dx.doi.org/10.1016/j.neulet.2006.05.049

Gresle M; Jarrott B; Jones N; Callaway J, 2006, 'Injury to axons and oligodendrocytes following endothelin-1-induced middle cerebral artery occlusion in conscious rats', Brain Research Reviews, 1110, pp. 13 - 22, http://dx.doi.org/10.1016/j.brainres.2006.06.111

Cimarosti H; O''shea R; Jones N; Horn A; L ; Nassif M; Frozza R; Netto C; Beart P; Salbego C, 2006, 'The effects of estradiol on Glutamate Transporters and estrogen receptors and glutamate transporters in organotypic cultures exposed to oxygen-glucose deprivation.', Neurochemical Research, 31, pp. 483 - 490, http://dx.doi.org/10.1007/s11064-006-9043-9

Cimarosti H; Jones NM; O'Shea RD; Pow DV; Salbego C; Beart PM, 2005, 'Hypoxic preconditioning in neonatal rat brain involves regulation of excitatory amino acid transporter 2 and estrogen receptor alpha', Neuroscience Letters, 385, pp. 52 - 57, http://dx.doi.org/10.1016/j.neulet.2005.05.006

Jones NM; Beart PM, 2005, 'Hypoxic preconditioning increases expression of HIF prolyl hydroxylase 2 (Egln1) in neonatal rat brain', Journal of Cerebral Blood Flow & Metabolism, 25, pp. S312 - S312, http://dx.doi.org/10.1038/sj.jcbfm.9591524.0312

Jones N; Bergeron M, 2004, 'Hypoxia-induced tolerance in neonatal rat brain involves enhanced ERK1/2 signalling', Journal of Neurochemistry, 89, pp. 157 - 167, http://dx.doi.org/10.1111/j.1471-4159.2004.02324.x

Jones NM; Bergeron M, 2001, 'Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain', Journal of Cerebral Blood Flow and Metabolism, 21, pp. 1105 - 1114, http://dx.doi.org/10.1097/00004647-200109000-00008

Mercer LD; Le VQ; Nunan J; Jones NM; Beart PM, 2000, 'Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies', Neuroscience Letters, 293, pp. 167 - 170, http://dx.doi.org/10.1016/S0304-3940(00)01504-4

Bond A; Jones NM; Hicks CA; Whiffin GM; Ward MA; O'Neill MF; Kingston AE; Monn JA; Ornstein PL; Schoepp DD; Lodge D; O'Neill MJ, 2000, 'Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo', Journal of Pharmacology and Experimental Therapeutics, 294, pp. 800 - 809

Li XC; Beart PM; Monn JA; Jones NM; Widdop RE, 1999, 'Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats', British Journal of Pharmacology, 128, pp. 823 - 829, http://dx.doi.org/10.1038/sj.bjp.0702850

Jones NM; Beart PM; Monn JA; Widdop RE, 1999, 'Type I and II metabotropic glutamate receptors mediate depressor and bradycardic actions in the nucleus of the solitary tract of anaesthetized rats', European Journal of Pharmacology, 380, pp. 129 - 135, http://dx.doi.org/10.1016/S0014-2999(99)00518-X

Jones NM; Monn JA; Beart PM, 1998, 'Type I and II metabotropic glutamate receptors regulate the outflow of [³H]d-aspartate and [¹⁴C]γ-aminobutyric acid in rat solitary nucleus', European Journal of Pharmacology, 353, pp. 43 - 51, http://dx.doi.org/10.1016/S0014-2999(98)00394-X

Back to profile page